Aclaris Therapeutics ACRS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.53 | -0.12 | -17,784 | -15 | ||
| 2024Q4 | 2.48 | 103.23 | -1.21 | -99,675 | -97 | |
| 2024Q3 | 1.15 | 138.03 | -0.11 | -10,471 | -8 | |
| 2024Q2 | 1.10 | 117.01 | -0.15 | -12,855 | -11 | |
| 2024Q1 | 1.24 | 111.75 | -0.24 | -18,931 | -17 | |
| 2023Q4 | 1.05 | 217.81 | -0.02 | -4,047 | -1 | |
| 2023Q3 | 6.85 | 107.91 | -0.41 | -31,577 | -29 | |
| 2023Q2 | 10.37 | 107.60 | -0.42 | -31,815 | -30 | |
| 2023Q1 | 8.09 | 106.24 | -0.42 | -29,918 | -28 | |
| 2022Q4 | 15.75 | 105.23 | -0.41 | -29,079 | -28 | |
| 2022Q3 | 15.74 | 104.62 | -0.30 | -20,874 | -20 | |
| 2022Q2 | 13.96 | 102.25 | -0.31 | -20,994 | -21 | |
| 2022Q1 | 17.24 | 100.63 | -0.31 | -18,907 | -19 | |
| 2021Q4 | 14.54 | 100.39 | -0.37 | -22,893 | -23 | |
| 2021Q3 | 18.00 | 95.98 | -0.33 | -20,295 | -21 | |
| 2021Q2 | 17.56 | 99.15 | -0.33 | -18,006 | -18 | |
| 2021Q1 | 25.20 | 99.22 | -0.57 | -28,529 | -29 | |
| 2020Q4 | 6.47 | 98.41 | -0.30 | -13,560 | -13 | |
| 2020Q3 | 2.57 | 98.18 | -0.25 | -10,465 | -11 | |
| 2020Q2 | 1.62 | 98.37 | -0.28 | -11,381 | -12 |